adcom

Drug Approvals and FDA AdComms in 2023

Having passed the mid-year point, it is always an interesting exercise to take stock of where we stand with respect to the approval of new medicines. Overall, when considering the volume of activity, things would seem to be looking up … Continue reading




adcom

The Year in AdComms – A Look Back at 2023

For those working closely with the development of new medicines for FDA approval, it can be informative respecting the future to look back at recent activity and take note of any potential changes from years past. Now, with no more … Continue reading




adcom

FDA Adds New AdComm to Address Genetic Metabolic Diseases

Back in December 2023, FDA announced intention in the Federal Register and in a press release to form a new FDA Advisory Committee to be called the Genetic Metabolic Diseases Advisory Committee (GeMDAC). As noted in a recent posting here, … Continue reading




adcom

300 percent price hikes push disgruntled VMware customers toward Broadcom rivals

Ars speaks with users and partners unhappy with Broadcom's changes.




adcom

OpenAI builds first chip with Broadcom and TSMC, scales back foundry ambition

OpenAI is working with Broadcom and TSMC to build its first in-house chip designed to support its artificial intelligence systems, per sources




adcom

Broadcom Wi-Fi KR00K Proof Of Concept

Broadcom Wi-Fi device KR00K information disclosure proof of concept exploit. It works on WPA2 AES CCMP with Frequency 2.4GHz WLANs.




adcom

US lawmakers scrutinise Broadcom bid for Qualcomm

Mnuchin urged to examine ‘deeply concerning’ takeover attempt by Singapore chipmaker




adcom

RSGB’s RadCom Magazine May Edition Available to All Online